Shilpa Medicare Ltd

Shilpa Medicare Ltd

$SHILPAMEDPharmaceuticalsNSEBSE

Shilpa Medicare Ltd (SHILPAMED) last traded at ₹856, a market capitalisation of ₹16,742 crore, on a P/E of 58.9. Over the past 52 weeks the stock has ranged between ₹260 and ₹867. Shilpa Medicare Ltd last reported results for the quarter ended Jun 2026, with sales of ₹466 crore and net profit of ₹101 crore. The next scheduled event is a record date on 4 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.

Shilpa Medicare Ltd share price and key metrics

Current price
₹856
Market cap
₹16,742 cr
Stock P/E
58.9
Book value
₹132
ROE
8.99%
ROCE
10.9%
Dividend yield
0.07%
52w high / low
867/260

Metrics as of 25 Aug 2026. Not real time.

Shilpa Medicare Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹466 cr, up 45.2% from ₹321 cr a year earlier. Net profit was ₹101 cr, up 114.9% year on year.

Shilpa Medicare Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales344319331321370410437466
Expenses258239252231262296317330
Operating profit86817991108114120136
OPM %25%25%24%28%29%28%27%29%
Other income52-2162-13459
Interest2612141916111412
Depreciation2829292930303135
Profit before tax37421550646112098
Tax %51%24%5%5%32%27%10%-3%
Net profit183215474445108101
EPS (₹)0.921.620.742.402.252.285.515.16

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Shilpa Medicare Ltd annual results

Shilpa Medicare Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales8991,1411,0461,1461,2811,5351,683
Operating profit18120299239319435479
OPM %20%18%9%21%25%28%28%
Net profit14661-313278243297
EPS (₹)9.063.49-1.871.844.0012.4415.20

TTM is the trailing twelve months to the most recent quarter.

Shilpa Medicare Ltd growth and returns

Compounded Sales Growth
10 Years
8%
5 Years
11%
3 Years
14%
TTM
28%
Compounded Profit Growth
10 Years
8%
5 Years
17%
3 Years
107%
TTM
117%
Stock Price CAGR
10 Years
12%
5 Years
24%
3 Years
68%
1 Year
102%
Return on Equity
10 Years
6%
5 Years
4%
3 Years
5%
Last Year
9%

Shilpa Medicare Ltd shareholding pattern

Promoters held 40.13% at Jun 2026, down from 44.23% at Jun 2025. FIIs 11.39% and DIIs 8.05%.

Shilpa Medicare Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters44.33%44.23%44.23%44.23%44.23%40.13%40.13%40.13%
FIIs9.59%9.90%10.97%11.19%10.92%10.97%11.07%11.39%
DIIs8.18%8.27%7.55%7.46%7.67%8.34%8.58%8.05%
Public37.90%37.59%37.25%37.10%37.18%40.56%40.21%40.42%
No. of shareholders42,78449,03450,10848,63652,06553,79953,41060,926

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

Upcoming Shilpa Medicare Ltd events

The next scheduled event is a record date on 4 Sept 2026.

  • Record dateRecord date for final dividend payment
  • AGM39th Annual General Meeting to transact business including final dividend declaration

See the full results calendar for every Indian company reporting in the next 30 days.

Shilpa Medicare Ltd corporate filings

  • Dispatch of letter to shareholders whose e-mail addresses are not registered with Company/ Registrar & Transfer Agent/ Depository Participants.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Shilpa Medicare Ltd has initiated the dispatch of letters to shareholders who have not…

    Read the full analysis
  • Disclosure under Reg.30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.Company Updatemedium impact
    Filing PDF

    Cruxal's analysis: Shilpa Medicare has issued a formal response to media reports regarding the recall of…

    Read the full analysis
  • Dividend Update Corp Actionlow impact
    Filing PDF

    Cruxal's analysis: Shilpa Medicare Limited has issued a formal communication to shareholders regarding the…

    Read the full analysis
  • Newspaper PublicationCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Shilpa Medicare Ltd has fulfilled its regulatory obligation under Regulation 30 of the…

    Read the full analysis
  • Annual Report of Shilpa Medicare Limited for the FY 2025-26Otherslow impact
    Filing PDF

    Cruxal's analysis: Shilpa Medicare Limited has filed its Annual Report for the financial year 2025-26 as per…

    Read the full analysis
  • 39th Annual General Meeting NoticeAGM/EGMlow impact
    Filing PDF

    Cruxal's analysis: Shilpa Medicare Limited has issued a notice for its 39th Annual General Meeting (AGM) to…

    Read the full analysis
  • Q1FY27 earnings conference call transcriptCompany Updatehigh impact
    Filing PDF

    Cruxal's analysis: Shilpa Medicare Limited delivered a strong performance in Q1 FY27, reporting record…

    Read the full analysis
  • Audio link of the Investor Conference call for Q1 FY27Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Shilpa Medicare has provided the audio link for the investor conference call held…

    Read the full analysis
  • Investor Presentation for Q1FY27Company Updatehigh impact
    Filing PDF

    Cruxal's analysis: Shilpa Medicare Limited delivered robust 1QFY27 financial results, reporting revenue of…

    Read the full analysis
  • The record date for determining the shareholders entitled for payment of final dividend for FY 2025-26, if declared at the 39th AGM is Friday, 4th September 2026.Corp. Actionlow impact
    Filing PDF

    Cruxal's analysis: Shilpa Medicare Limited has formally announced Friday, 4 September 2026, as the Record…

    Read the full analysis
  • Unaudited Financial Results for the Quarter ended 30 June 2026Board Meetinghigh impact
    Filing PDF

    Cruxal's analysis: Shilpa Medicare Limited reported robust financial performance for the quarter ended 30…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Shilpa Medicare Ltd

Cruxal reads every Shilpa Medicare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.

Shilpa Medicare Ltd (SHILPAMED) Results, Financials & Share Price | Cruxal